Suchergebnisse - "Held, Gerhard"

PubPharm (18)

1

Genetic Characterization of Primary Mediastinal B-Cell Lymphoma : Pathogenesis and Patient Outcomes

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Noerenberg, D. | Briest, F. | Hennch, C. | +30

2

Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP

enthalten in: Haematologica | 2023

von Bewarder, M. | Kaddu-Mulindwa, D. | Kos, I. | +12

3

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma : a LYSA and GLA/DSHNHL analysis

enthalten in: Blood advances | 2023

von Thieblemont, C. | Altmann, B. | Frontzek, F. | +19

4

Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP : an analysis of the FLYER-trial

enthalten in: Leukemia & lymphoma | 2022

von Kaddu-Mulindwa, D. | Lesan, V. | Berdel, C. | +14

5

KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab : a post-hoc analysis of the RICOVER-60 and CLL8 trials

enthalten in: The Lancet. Haematology | 2022

von Kaddu-Mulindwa, D. | Altmann, B. | Robrecht, S. | +19

CommentIn: Lancet Haematol. 2022 Feb;9(2):e88-e89. - PMID 35114157

6

Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma : analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma-data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin's Lymphoma Study Group)

enthalten in: Annals of hematology | 2021

von Zettl, F. | Ziepert, M. | Altmann, B. | +9

7

VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma

enthalten in: European journal of haematology | 2021

von Kaddu-Mulindwa, D. | Rosolowski, M. | Ziepert, M. | +6

8

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma : the DSHNHL2006-1B/ACT-2 trial

enthalten in: Leukemia | 2021

von Wulf, G. | Altmann, B. | Ziepert, M. | +26

9

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) : a randomised, phase 3, non-inferiority trial

enthalten in: Lancet (London, England) | 2019

von Poeschel, V. | Held, G. | Ziepert, M. | +43

CommentIn: Lancet. 2020 Dec 21;394(10216):2208-2209. - PMID 31868615

10

Optimization of rituximab for the treatment of DLBCL : increasing the dose for elderly male patients

enthalten in: British journal of haematology | 2017

von Pfreundschuh, M. | Murawski, N. | Zeynalova, S. | +16